Introduction
It has been known for many years that there are histamine receptors (H) in the heart. 1 Histamine receptors are divided into four subtypes H1, Hs, H3 and H4. 2 Histamine and its antagonists, such as cimetidine, have direct chronotropic and dromotropic effects. 3 Histamine also modulates norepinephrine release from the cardiac sympathetic nerve, such as endothelin. [4] [5] [6] Thus, in essence, histamine is a true neuro-hormone.
Mast cells are found in the heart and are known to release histamine. 7 Mast cells and histamine release have been implicated in human heart disease. 7, 8 In addition to histamine release, mast cells appear to be a unique source of renin. 9 Thus, in some cases, histamine might contribute to the local activation of the renin-angiotensin-aldosterone system in the heart and all of the potential adverse consequences of that particular neuro-hormonal system. Using an isolated Langendorff preparation, Mackins et al. 10 demonstrated that cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in an ischemic/reperfusion model and that mast cell stabilization with cromolyn or iodoxamide attenuates this process. The elevation of serum histamine and mast cells accumulation in the heart were observed during heart failure in human patients. 7 In addition, H2 blockers have been demonstrated to prolong survival time during heart failure in human patients. 11 Collectively, these data suggest that histamine might play an important role in heart disease. However, to the best of our knowledge, there are no reported studies that have investigated the role of histamine in canine valvular disease (CVD). Therefore, the aim of this study was to evaluate the histamine serum concentrations of affected and unaffected dogs.
Materials and Methods
Client-owned dogs suffering from chronic valvular disease (mitral regurgitation; n=21) and healthy controls (n=7) were examined. Summary of clinical data of the experimental groups are in Table 1 . Disease diagnoses were established by physical examination, electrocardiography, thoracic radiography, 2-D and Doppler echocardiography, as well as blood examination (complete blood counts, biochemistry, C-reactive protein). All of the animals were negative for Dirofilaria immitis infection. All patients did not have concurrent diseases at the time of measurement for plasma histamine. The dogs suffering from valvular disease were administered enalapril or ramipril, spironolactone, furosemide or torasemide, pimobendan, or isosorbide dinitrate, dependent on the condition of the disease. Serum histamine concentrations were measured in all animals. Control: Cavalier King Charles Spaniel n=3, T. Poodle n=1, Mix breed n=1, G. Retriever n=1, Pomeranian n=1. For the CVHD grades, class I: Cavalier King Charles Spaniel n=2, Pug n=1, Papillon n=1, Mix breed n=1, Pomeranian n=1. Class II: Norfolk Terrier n=1, Chihuahua n=1, Maltese n=1, Cavalier King Charles Spaniel n=1, Shih Tzu n=1, Mix breed n=1. Class III: Chihuahua n=2, Shih Tzu n=2, French Bulldogs n=1, Cavalier King Charles Spaniel n=2, Beagle n=1, Mix breed n=1. All patients did not have concurrent diseases at the time of measurement for plasma histamine. The dogs suffering from valvular disease were administered enalapril or ramipril, spironolactone, furosemide or torasemide, pimobendan, or isosorbide dinitrate, dependent on the condition of the disease. The serum samples were maintained at -20°C until the experiments were performed. A commercial enzyme-linked immunosorbent assay (ELISA) kit (SPI Bio, Bertin Pharma Inc., Montigny le Bretonneux, France) was utilized, and the histamine concentrations of the healthy and CVD samples were compared and also investigated using the correlation between the ISACHC (International Small Animal Cardiac Heart Council) classification and heart murmur intensity. 12 The data are expressed as the mean ± standard error. An unpaired t-test was used for comparisons between the healthy and valvular heart disease dogs ( Figure 1A ). An ANOVA post hoc Bonferroni test was used to compare the healthy and ISACHC-classified dogs ( Figure 1B) . We also evaluated the correlation between the grade of heart murmur and the histamine concentration (Figure 2) . A value of P<0.05 was considered statistically significant. All analyses were performed using commercial statistical software (StatMate v.
4.01).
Twenty-eight client-owned dogs were enrolled in this study, which included 7 healthy control dogs and 21 dogs suffering from CVD. The CVD dogs were divided into ISACHC classes I, II and III. The control group dogs (n=7) had body weights of 9.2±2.5 kg and were 116.3±12.6 months old in age. Class I (n=6) had body weights of 7.3±1.2 kg and were 105.5±26.9 months old in age, Class II (n=6) had body weights of 6.3±1.0 kg and were 102.2±18.3 months old in age, and Class III (n=9) had body weights of 8.0±2.7 kg and were 129.0±7.7 months old in age.
The dogs suffering from CVD had higher histamine concentrations (63.2±25. compared to the healthy control dogs (13.1±7.6 nM, P<0.01; Figure 1A ). Among the ISACHC grades, Class 1: n=6: 45.4±16.1 (nM), Class 2: n=6: 53.8±27.5 (nM), and Class 3: n=9: 80.4±20.3 (nM); Figure 1B . Thus, the histamine concentration gradually elevated dependent on the ISACHC grade. There was significant relationship between murmur grade and histamine concentration in the dogs suffering from CVD (r=0.559; P<0.01; Figure 2 ). These results indicate that the histamine concentration was higher in the CVD population of dogs compared to the healthy controls. Although it appears clear that a genetic basis exists for CVD development, the results of this study support the growing body of evidence that inflammatory mediators may contribute to the deterioration of heart valves over time. 13 
Discussion
In a canine heart failure model, histamine expression was elevated, and mast cells were collected in cardiomyocytes. 8 In addition, the blood histamine concentration is elevated during human heart failure. 7 A number of studies have also investigated whether inflammation plays a role in the progression of CVD and cardiac ischemia/reperfusion. 4, [13] [14] [15] [16] Collectively, the phenomena involved in this study might be related. The results of this study suggest that there may be an underlying systemic inflammatory process involved in heart disease. However, in our study, we did not evaluate the associations among histamine and other inflammatory substances. Thus, an elevated histamine concentration might be associated with other substances. In our study, there was a good correlation between heart murmur intensity and histamine concentration, and this phenomenon is not similar to the results found between heart murmur and C-reactive protein in dogs. 13 This discrepancy is not clear; however, a proinflammatory reaction might be associated with heart disease in dogs.
In the clinical setting, a combination of beta blockers and blocking histamine production (H2 blocker) showed a significant improvement in cardiac function, as demonstrated by echocardiography, compared to the administration of beta blocker alone. 8 Thus, histamine blockers might be useful for the treatment of canine valvular disease in the future.
Conclusions
In conclusion, the histamine concentration was higher in the population of dogs suffering from CVD compared to the healthy controls. The pathogenesis of CVD is complex, not fully understood, and likely relates to certain systemic inflammations, such as histamine production. Ultimately more studies will be required to determine whether histamine measurements can be useful in assessing or managing dogs suffering from cardiac valvular disease.
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